A new anti-fibrotic drug attenuates cardiac remodeling and systolic dysfunction following experimental myocardial infarction.

[1]  Spencer J. Williams,et al.  FT011, a new anti‐fibrotic drug, attenuates fibrosis and chronic heart failure in experimental diabetic cardiomyopathy , 2012, European journal of heart failure.

[2]  C. Murphy,et al.  Age-Dependent Expression of Collagen Receptors and Deformation of Type I Collagen Substrates by Rat Cardiac Fibroblasts , 2011, Microscopy and Microanalysis.

[3]  A. Coats,et al.  Ethics in the authorship and publishing of scientific articles , 2010 .

[4]  Yuan Zhang,et al.  Effect of atorvastatin on cardiac remodelling and mortality in rats following hyperglycemia and myocardial infarction. , 2010, International journal of cardiology.

[5]  Spencer J. Williams,et al.  Evaluation and optimization of antifibrotic activity of cinnamoyl anthranilates. , 2009, Bioorganic & medicinal chemistry letters.

[6]  H. Krum,et al.  Effects of a Rho kinase inhibitor on pressure overload induced cardiac hypertrophy and associated diastolic dysfunction. , 2008, American journal of physiology. Heart and circulatory physiology.

[7]  Yuan Zhang,et al.  Functional, structural and molecular aspects of diastolic heart failure in the diabetic (mRen-2)27 rat. , 2007, Cardiovascular research.

[8]  H. Krum,et al.  Tranilast attenuates diastolic dysfunction and structural injury in experimental diabetic cardiomyopathy. , 2007, American journal of physiology. Heart and circulatory physiology.

[9]  J. Olgin,et al.  Pirfenidone Prevents the Development of a Vulnerable Substrate for Atrial Fibrillation in a Canine Model of Heart Failure , 2006, Circulation.

[10]  R. Ferrari,et al.  Experimental ischemic cardiomyopathy: insights into remodeling, physiological adaptation, and humoral response. , 2006, Annals of clinical and laboratory science.

[11]  R. Gilbert,et al.  Tranilast attenuates connective tissue growth factor-induced extracellular matrix accumulation in renal cells. , 2006, Kidney international.

[12]  Yuan Zhang,et al.  Inhibition of protein kinase C reduces left ventricular fibrosis and dysfunction following myocardial infarction. , 2005, Journal of molecular and cellular cardiology.

[13]  Yuan Zhang,et al.  Tranilast attenuates cardiac matrix deposition in experimental diabetes: role of transforming growth factor-beta. , 2005, Cardiovascular Research.

[14]  H. Krum,et al.  Fibrosis as a therapeutic target post-myocardial infarction. , 2005, Current pharmaceutical design.

[15]  P. Ghezzi,et al.  Antioxidant treatment attenuates hyperglycemia-induced cardiomyocyte death in rats. , 2004, Journal of molecular and cellular cardiology.

[16]  H. Krum,et al.  p38 mitogen-activated protein kinase inhibition improves cardiac function and attenuates left ventricular remodeling following myocardial infarction in the rat. , 2004, Journal of the American College of Cardiology.

[17]  Yuan Zhang,et al.  Tranilast attenuates structural and functional aspects of renal injury in the remnant kidney model. , 2004, Journal of the American Society of Nephrology : JASN.

[18]  T. Huynh,et al.  Inhibition of COX pathway in experimental myocardial infarction. , 2004, Journal of molecular and cellular cardiology.

[19]  H. Krum,et al.  Direct Actions of Urotensin II on the Heart: Implications for Cardiac Fibrosis and Hypertrophy , 2003, Circulation research.

[20]  H. Krum,et al.  Tranilast inhibits pathological collagen deposition, independent of haemodynamic alteration, following myocardial infarction in the rat , 2003 .

[21]  S. Solomon,et al.  Renin-angiotensin system and cardiac rupture after myocardial infarction. , 2002, Circulation.

[22]  B. Davis,et al.  Results of Prevention of REStenosis with Tranilast and its Outcomes (PRESTO) Trial , 2002, Circulation.

[23]  R. Hannan,et al.  Adenoviral-Directed Expression of the Type 1A Angiotensin Receptor Promotes Cardiomyocyte Hypertrophy via Transactivation of the Epidermal Growth Factor Receptor , 2002, Circulation research.

[24]  M. Kinoshita,et al.  Effect of spironolactone on plasma brain natriuretic peptide and left ventricular remodeling in patients with congestive heart failure. , 2001, Journal of the American College of Cardiology.

[25]  Ronald R. Watson,et al.  Validation of Conductance Catheter System for Quantification of Murine Pressure-Volume Loops , 2001, Journal of investigative surgery : the official journal of the Academy of Surgical Research.

[26]  P. Hildebrandt,et al.  Antiremodeling effects on the left ventricle during beta-blockade with metoprolol in the treatment of chronic heart failure. , 2000, Journal of the American College of Cardiology.

[27]  F. Alla,et al.  Limitation of Excessive Extracellular Matrix Turnover May Contribute to Survival Benefit of Spironolactone Therapy in Patients With Congestive Heart Failure: Insights From the Randomized Aldactone Evaluation Study (RALES) , 2000, Circulation.

[28]  E. Bottinger,et al.  Smad proteins and transforming growth factor-β signaling , 2000 .

[29]  K. Weber,et al.  Infarct scar: a dynamic tissue. , 2000, Cardiovascular research.

[30]  J. Massagué,et al.  Controlling TGF-β signaling , 2000, Genes & Development.

[31]  Allen M. Gown,et al.  Complete Chromogen Separation and Analysis in Double Immunohistochemical Stains Using Photoshop-based Image Analysis , 1999, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[32]  D. Nisato,et al.  Effects of long-term angiotensin II AT1 receptor blockade on survival, hemodynamics and cardiac remodeling in chronic heart failure in rats. , 1999, Cardiovascular research.

[33]  B. Swynghedauw,et al.  Molecular mechanisms of myocardial remodeling. , 1999, Physiological reviews.

[34]  K. Weber,et al.  Cardiac remodelling by fibrous tissue: role of local factors and circulating hormones. , 1998, Annals of medicine.

[35]  D. Kass,et al.  In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry. , 1998, American journal of physiology. Heart and circulatory physiology.

[36]  G. Jerums,et al.  Expression of transforming growth factor-beta1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: effects of ACE inhibition. , 1998, Diabetes.

[37]  David A. Mankoff,et al.  Application of Photoshop-based Image Analysis to Quantification of Hormone Receptor Expression in Breast Cancer , 1997, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[38]  R. Walsh,et al.  In vivo Echocardiographic Assessment of Left Ventricular Function in Transgenic and Gene-Targeted Mice. , 1997, Trends in cardiovascular medicine.

[39]  R. Walsh,et al.  In vivo determination of left ventricular wall stress-shortening relationship in normal mice. , 1997, The American journal of physiology.

[40]  H. Fliss,et al.  Apoptosis in ischemic and reperfused rat myocardium. , 1996, Circulation research.

[41]  John Calvin Reed,et al.  Apoptotic and necrotic myocyte cell deaths are independent contributing variables of infarct size in rats. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[42]  M. Quiñones,et al.  Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy. , 1995, Circulation.

[43]  K. Weber,et al.  Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. , 1994, Journal of molecular and cellular cardiology.

[44]  W L Stahl,et al.  Fundamentals of quantitative autoradiography by computer densitometry for in situ hybridization, with emphasis on 33P. , 1993, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[45]  E. Ruoslahti,et al.  Negative regulation of transforming growth factor-β by the proteoglycan decorin , 1990, Nature.

[46]  N. Reichek,et al.  Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. , 1989, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[47]  M. O’Connor-McCourt,et al.  Latent transforming growth factor-beta in serum. A specific complex with alpha 2-macroglobulin. , 1987, The Journal of biological chemistry.

[48]  A. Bourthoumieux.  [Cardiac catheterization. 2]. , 1967, Revue de l'infirmiere et de l'assistante sociale.